101 related articles for article (PubMed ID: 1338280)
1. Beta-adrenergic influences on doxorubicin-sensitive or -resistant P388 leukemia cells.
D'Amico C; Crescimanno M; Armata MG; Leonardi V; Palazzoadriano M; D'Alessandro N
Anticancer Res; 1992; 12(6B):2253-6. PubMed ID: 1338280
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
Hait WN; Pierson NR
Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
Jasper JR; Motulsky HJ; Insel PA
J Pharmacol Exp Ther; 1988 Mar; 244(3):820-4. PubMed ID: 2908047
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone differentially regulates development of beta-adrenergic receptors, adenylate cyclase and ornithine decarboxylase in rat heart and kidney.
Pracyk JB; Slotkin TA
J Dev Physiol; 1991 Oct; 16(4):251-61. PubMed ID: 1667405
[TBL] [Abstract][Full Text] [Related]
5. Number and functionality of beta-adrenergic receptors in the mouse lymphocytic P388 leukemia as a doxorubicin-sensitive and -resistant variant.
D'Amico C; Crescimanno M; Armata MG; Leonardi V; Palazzoadriano M; D'Alessandro N
Pharmacol Res; 1992 Sep; 26 Suppl 2():168-9. PubMed ID: 1357644
[No Abstract] [Full Text] [Related]
6. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
[TBL] [Abstract][Full Text] [Related]
7. beta-Adrenergic receptors and adenylate cyclase activity in murine lymphoid cell lines.
Staehelin M; Müller P; Portenier M; Harris AW
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):55-64. PubMed ID: 2984265
[TBL] [Abstract][Full Text] [Related]
8. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
Ramu A; Cohen L; Glaubiger D
Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic receptors and myogenesis.
Schonberg M; Bilezikian JP; Apfelbaum M; Benn RC
J Cyclic Nucleotide Res; 1978 Feb; 4(1):55-69. PubMed ID: 205563
[TBL] [Abstract][Full Text] [Related]
10. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
Marsh JD; Smith TW
Mol Pharmacol; 1985 Jan; 27(1):10-8. PubMed ID: 2981398
[TBL] [Abstract][Full Text] [Related]
11. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
Barovsky K; Pedone C; Brooker G
Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
[TBL] [Abstract][Full Text] [Related]
12. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
13. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
Sanae F; Miyamoto K; Koshiura R
Cancer Res; 1989 Nov; 49(22):6242-6. PubMed ID: 2553251
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
Debernardi MA; Munshi R; Brooker G
Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
[TBL] [Abstract][Full Text] [Related]
15. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
Nair S; Horton A; Leif RC; Krishan A
Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
[TBL] [Abstract][Full Text] [Related]
16. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
Nori M; Gothoskar BP
Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
[TBL] [Abstract][Full Text] [Related]
17. Comparison of beta adrenergic receptor binding characteristics and coupling to adenylate cyclase in rat pulmonary artery versus aorta.
Shaul PW; Muntz KH; Buja LM
J Pharmacol Exp Ther; 1990 Jan; 252(1):86-92. PubMed ID: 2153813
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
Pfeil D; Bergmann J; Fichtner I; Stein U; Hentschel M; Rothe I; Goan SR
Anticancer Res; 1994; 14(2A):571-6. PubMed ID: 7912495
[TBL] [Abstract][Full Text] [Related]
19. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide.
Ido M; Sato K; Sakurai M; Inagaki M; Saitoh M; Watanabe M; Hidaka H
Cancer Res; 1987 Jul; 47(13):3460-3. PubMed ID: 3581082
[TBL] [Abstract][Full Text] [Related]
20. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells.
Pittman RN; Molinoff PB
Mol Pharmacol; 1983 Nov; 24(3):398-408. PubMed ID: 6138704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
